A novel cuproptosis-related lncRNA prognostic risk score model for gastric cancer based on bioinformatics

Objective To establish an effective cuproptosis-related long non-coding ribonucleic acid (lncRNA) (CRL) prognostic risk score (RS) model (CRLPRSM) for the prediction of the outcomes of patients with gastric cancer (GC). Introduction Cuproptosis is an up-to-date mode of cell death, and its action mec...

Full description

Bibliographic Details
Main Authors: Xue Du, Yu Xiao, Chunbao Chen, Lu Yang, Yu Cui, Tingting Wu, Bangxian Tan
Format: Article
Language:English
Published: SAGE Publishing 2022-09-01
Series:European Journal of Inflammation
Online Access:https://doi.org/10.1177/1721727X221128266
_version_ 1811182274502197248
author Xue Du
Yu Xiao
Chunbao Chen
Lu Yang
Yu Cui
Tingting Wu
Bangxian Tan
author_facet Xue Du
Yu Xiao
Chunbao Chen
Lu Yang
Yu Cui
Tingting Wu
Bangxian Tan
author_sort Xue Du
collection DOAJ
description Objective To establish an effective cuproptosis-related long non-coding ribonucleic acid (lncRNA) (CRL) prognostic risk score (RS) model (CRLPRSM) for the prediction of the outcomes of patients with gastric cancer (GC). Introduction Cuproptosis is an up-to-date mode of cell death, and its action mechanism is different from all other known mechanisms that regulate cell death. LncRNAs are RNA species that are over 200 nt long and do not encode proteins. They have prominent actions in tumor onset and development, and their involvement in a variety of intracellular regulatory processes is vital for cell proliferation and differentiation, so they may serve as prognostic biomarkers in tumor patients. Methods We retrieved cuproptosis-associated clinical and lncRNA expression data of GC cases from The Cancer Genome Atlas Stomach Adenocarcinoma (TCGA-STAD). Then a CRLPRSM was built based on univariate and multivariate Cox regression (UCR and MCR) analyses. As per the RS, the patients fell into high- and low-risk group. Later, the predictive efficacy of the CRLPRSM was confirmed with the aid of Kaplan-Meier (KM) analysis and receiver operating characteristic (ROC) curve analysis. Next, combining independent prognostic factors in clinical characteristics, we plotted a prognosis-related nomogram to predict one-year, three-year and five-year overall survival (OS) in GC patients. Finally, we implemented Gene Ontology enrichment analysis (GOEA) and Kyoto Encyclopedia of Genes and Genomes enrichment analysis (KEGGEA) for clarifying the possible biological actions and molecular mechanisms. Results The constructed CRLPRSM consisted of 3 CRLs, namely, AC092574.1, MAGI2-AS3, AC090204.1. It was found that the hazard ratio (HR) was 1.911 (1.337–2.731) ( p < 0.001) in UCR analysis and 1.852 (1.286–1.668) ( p < 0.001) in MCR analysis, and the AUC of the CRLPRSM was 0.649. Moreover, the KM analysis showed a pronounced intergroup difference in survival, and the nomogram illustrated some clinical benefits of CRLPRSM. Furthermore, GO terms and KEGG pathways were unveiled to be significantly enriched. Conclusion The constructed CRLPRSM has a significant predicted value for GC patient prognosis, and CRLs may become novel hallmarks for clinical treatment of GC.
first_indexed 2024-04-11T09:30:06Z
format Article
id doaj.art-55500c0ab403486a81b503484d2cb50f
institution Directory Open Access Journal
issn 2058-7392
language English
last_indexed 2024-04-11T09:30:06Z
publishDate 2022-09-01
publisher SAGE Publishing
record_format Article
series European Journal of Inflammation
spelling doaj.art-55500c0ab403486a81b503484d2cb50f2022-12-22T04:31:55ZengSAGE PublishingEuropean Journal of Inflammation2058-73922022-09-012010.1177/1721727X221128266A novel cuproptosis-related lncRNA prognostic risk score model for gastric cancer based on bioinformaticsXue DuYu XiaoChunbao ChenLu YangYu CuiTingting WuBangxian TanObjective To establish an effective cuproptosis-related long non-coding ribonucleic acid (lncRNA) (CRL) prognostic risk score (RS) model (CRLPRSM) for the prediction of the outcomes of patients with gastric cancer (GC). Introduction Cuproptosis is an up-to-date mode of cell death, and its action mechanism is different from all other known mechanisms that regulate cell death. LncRNAs are RNA species that are over 200 nt long and do not encode proteins. They have prominent actions in tumor onset and development, and their involvement in a variety of intracellular regulatory processes is vital for cell proliferation and differentiation, so they may serve as prognostic biomarkers in tumor patients. Methods We retrieved cuproptosis-associated clinical and lncRNA expression data of GC cases from The Cancer Genome Atlas Stomach Adenocarcinoma (TCGA-STAD). Then a CRLPRSM was built based on univariate and multivariate Cox regression (UCR and MCR) analyses. As per the RS, the patients fell into high- and low-risk group. Later, the predictive efficacy of the CRLPRSM was confirmed with the aid of Kaplan-Meier (KM) analysis and receiver operating characteristic (ROC) curve analysis. Next, combining independent prognostic factors in clinical characteristics, we plotted a prognosis-related nomogram to predict one-year, three-year and five-year overall survival (OS) in GC patients. Finally, we implemented Gene Ontology enrichment analysis (GOEA) and Kyoto Encyclopedia of Genes and Genomes enrichment analysis (KEGGEA) for clarifying the possible biological actions and molecular mechanisms. Results The constructed CRLPRSM consisted of 3 CRLs, namely, AC092574.1, MAGI2-AS3, AC090204.1. It was found that the hazard ratio (HR) was 1.911 (1.337–2.731) ( p < 0.001) in UCR analysis and 1.852 (1.286–1.668) ( p < 0.001) in MCR analysis, and the AUC of the CRLPRSM was 0.649. Moreover, the KM analysis showed a pronounced intergroup difference in survival, and the nomogram illustrated some clinical benefits of CRLPRSM. Furthermore, GO terms and KEGG pathways were unveiled to be significantly enriched. Conclusion The constructed CRLPRSM has a significant predicted value for GC patient prognosis, and CRLs may become novel hallmarks for clinical treatment of GC.https://doi.org/10.1177/1721727X221128266
spellingShingle Xue Du
Yu Xiao
Chunbao Chen
Lu Yang
Yu Cui
Tingting Wu
Bangxian Tan
A novel cuproptosis-related lncRNA prognostic risk score model for gastric cancer based on bioinformatics
European Journal of Inflammation
title A novel cuproptosis-related lncRNA prognostic risk score model for gastric cancer based on bioinformatics
title_full A novel cuproptosis-related lncRNA prognostic risk score model for gastric cancer based on bioinformatics
title_fullStr A novel cuproptosis-related lncRNA prognostic risk score model for gastric cancer based on bioinformatics
title_full_unstemmed A novel cuproptosis-related lncRNA prognostic risk score model for gastric cancer based on bioinformatics
title_short A novel cuproptosis-related lncRNA prognostic risk score model for gastric cancer based on bioinformatics
title_sort novel cuproptosis related lncrna prognostic risk score model for gastric cancer based on bioinformatics
url https://doi.org/10.1177/1721727X221128266
work_keys_str_mv AT xuedu anovelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT yuxiao anovelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT chunbaochen anovelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT luyang anovelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT yucui anovelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT tingtingwu anovelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT bangxiantan anovelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT xuedu novelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT yuxiao novelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT chunbaochen novelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT luyang novelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT yucui novelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT tingtingwu novelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics
AT bangxiantan novelcuproptosisrelatedlncrnaprognosticriskscoremodelforgastriccancerbasedonbioinformatics